Track the 바이오솔루션 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 바이오솔루션 has logged 1 reports. Market capitalisation: €150.7bn. The latest transaction was reported on 12 March 2026 (Other). Among the most active insiders: 바이오솔루션. The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
BioSolution is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative biological solutions.